Stephan Jacob

9.1k total citations
70 papers, 2.8k citations indexed

About

Stephan Jacob is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology. According to data from OpenAlex, Stephan Jacob has authored 70 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Endocrinology, Diabetes and Metabolism, 28 papers in Molecular Biology and 22 papers in Physiology. Recurrent topics in Stephan Jacob's work include Diabetes Treatment and Management (28 papers), Metabolism, Diabetes, and Cancer (24 papers) and Diabetes Management and Research (16 papers). Stephan Jacob is often cited by papers focused on Diabetes Treatment and Management (28 papers), Metabolism, Diabetes, and Cancer (24 papers) and Diabetes Management and Research (16 papers). Stephan Jacob collaborates with scholars based in Germany, United States and United Kingdom. Stephan Jacob's co-authors include Erik J. Henriksen, K. Rett, Tyson R. Kinnick, Mary K. Teachey, Donovan L. Fogt, G. Dietze, M. Wicklmayr, Hans Tritschler, H J Augustin and Michael Krekler and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Diabetes.

In The Last Decade

Stephan Jacob

66 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephan Jacob Germany 30 1.0k 966 805 756 475 70 2.8k
K. Rett Germany 28 987 1.0× 1.4k 1.5× 858 1.1× 1.0k 1.4× 322 0.7× 83 3.4k
Nigishi Hotta Japan 28 676 0.7× 868 0.9× 693 0.9× 431 0.6× 259 0.5× 100 3.3k
Johan Van de Voorde Belgium 27 498 0.5× 1.8k 1.9× 1.1k 1.4× 1.1k 1.5× 229 0.5× 121 4.1k
Hirofumi Hitomi Japan 35 1.4k 1.4× 666 0.7× 942 1.2× 1.2k 1.6× 262 0.6× 98 3.7k
Carmine Savoia Italy 33 862 0.8× 607 0.6× 874 1.1× 1.6k 2.2× 252 0.5× 79 3.5k
Hiroshi Shinyama Japan 12 1.3k 1.3× 814 0.8× 402 0.5× 227 0.3× 337 0.7× 38 2.3k
Kazunori Utsunomiya Japan 32 1.6k 1.6× 582 0.6× 1.3k 1.6× 560 0.7× 323 0.7× 152 4.0k
Aurélie Nguyen Dinh Cat United Kingdom 27 1.2k 1.1× 622 0.6× 788 1.0× 975 1.3× 286 0.6× 42 2.9k
Andrea Semplicini Italy 35 1.0k 1.0× 758 0.8× 1.4k 1.7× 1.1k 1.4× 208 0.4× 165 4.0k
Felipe Inserra Argentina 33 626 0.6× 717 0.7× 790 1.0× 845 1.1× 186 0.4× 88 3.1k

Countries citing papers authored by Stephan Jacob

Since Specialization
Citations

This map shows the geographic impact of Stephan Jacob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Jacob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Jacob more than expected).

Fields of papers citing papers by Stephan Jacob

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan Jacob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Jacob. The network helps show where Stephan Jacob may publish in the future.

Co-authorship network of co-authors of Stephan Jacob

This figure shows the co-authorship network connecting the top 25 collaborators of Stephan Jacob. A scholar is included among the top collaborators of Stephan Jacob based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephan Jacob. Stephan Jacob is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eckel, Robert H., Andrew J. Krentz, Stephan Jacob, & Peter Libby. (2025). Global cardiometabolic alliance: A clinical and research initiative addressing the 21st century pandemic of insulin resistance‐associated disease. Diabetes Obesity and Metabolism. 27(11). 6101–6104.
2.
Heerspink, Hiddo J.L., Katherine R. Tuttle, Imre Pávó, et al.. (2024). Tirzepatide Reduces Albuminuria in Patients with T2D: Post-hoc Pooled Analysis of SURPASS 1-5. Diabetologie und Stoffwechsel. 19(S 01). S75–S75.
3.
Krentz, Andrew J., Stephan Jacob, Christian Heiß, et al.. (2024). Rising to the challenge of cardio-renal-metabolic disease in the 21st century: Translating evidence into best clinical practice to prevent and manage atherosclerosis. Atherosclerosis. 396. 118528–118528. 2 indexed citations
4.
Scherer, Jennifer S., et al.. (2022). Diabetes Management in Deutschland bei Typ 2 Diabetes -DiMiD2 – Real world data. Diabetologie und Stoffwechsel. 17(S 01). S70–S70.
5.
Schütt, Katharina, Jens Aberle, Johann Bauersachs, et al.. (2022). Positionspapier Herzinsuffizienz und Diabetes. Diabetologie und Stoffwechsel. 17(4). 277–288. 1 indexed citations
6.
7.
Harvey, Craig, et al.. (2016). Usability Evaluation of a Blood Glucose Monitoring System With a Spill-Resistant Vial, Easier Strip Handling, and Connectivity to a Mobile App. Journal of Diabetes Science and Technology. 10(5). 1136–1141. 12 indexed citations
8.
Jacob, Stephan, et al.. (2015). ‘Knowing what matters in diabetes. PubMed. 5(1). 14–20. 3 indexed citations
9.
Jacob, Stephan, Erik J. Henriksen, Hans Tritschler, H J Augustin, & G. Dietze. (2009). Improvement of insulin-stimulated glucose-disposal in type 2 diabetes after repeated parenteral administration of thioctic acid. Experimental and Clinical Endocrinology & Diabetes. 104(3). 284–288. 32 indexed citations
10.
Jacob, Stephan, et al.. (2009). Orlistat 120 mg improves glycaemic control in type 2 diabetic patients with or without concurrent weight loss. Diabetes Obesity and Metabolism. 11(4). 361–371. 55 indexed citations
11.
Jacob, Stephan, et al.. (2004). Typ-2-Diabetes, Störungen des Glukosestoffwechsels und vaskuläre Erkrankungen. Journal für Kardiologie (Krause & Pachernegg GmbH). 11(10). 392–395. 1 indexed citations
12.
Henriksen, Erik J., et al.. (2003). Isomer-specific actions of conjugated linoleic acid on muscle glucose transport in the obese Zucker rat. American Journal of Physiology-Endocrinology and Metabolism. 285(1). E98–E105. 73 indexed citations
13.
Henriksen, Erik J. & Stephan Jacob. (2003). Modulation of metabolic control by angiotensin converting enzyme (ACE) inhibition. Journal of Cellular Physiology. 196(1). 171–179. 99 indexed citations
14.
Keulen, Lucien van, et al.. (2001). Antihypertensive treatment and cardiovascular risk management in patients with the metabolic syndrome - Focus on SNS and insulin resistance. Journal of clinical and basic cardiology. 4(3). 193–195. 2 indexed citations
15.
Jacob, Stephan, Roland Becker, W. Renn, et al.. (1999). Lipolysis in skeletal muscle is rapidly regulated by low physiological doses of insulin. Diabetologia. 42(10). 1171–1174. 35 indexed citations
16.
Steen, Michelle S., et al.. (1999). Interactions of exercise training and ACE inhibition on insulin action in obese Zucker rats. Journal of Applied Physiology. 86(6). 2044–2051. 47 indexed citations
17.
Streeper, Ryan S., Erik J. Henriksen, Stephan Jacob, et al.. (1997). Differential effects of lipoic acid stereoisomers on glucose metabolism in insulin-resistant skeletal muscle. American Journal of Physiology-Endocrinology and Metabolism. 273(1). E185–E191. 95 indexed citations
18.
Jacob, Stephan, et al.. (1996). Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study.. PubMed. 14(4). 489–94. 184 indexed citations
19.
Henriksen, Erik J. & Stephan Jacob. (1995). Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats. Metabolism. 44(2). 267–272. 116 indexed citations
20.
Rett, K., Stephan Jacob, & M. Wicklmayr. (1994). Possible Synergistic Effect of ACE Inhibition and Calcium-Channel Blockade on Insulin Sensitivity in Insulin-Resistant Type II Diabetic Hypertensive Patients. Journal of Cardiovascular Pharmacology. 23(Supplement 1). S29–S33. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. Rett Breakdown of academic impact, for papers by Nigishi Hotta Breakdown of academic impact, for papers by Johan Van de Voorde Breakdown of academic impact, for papers by Hirofumi Hitomi Breakdown of academic impact, for papers by Carmine Savoia Breakdown of academic impact, for papers by Hiroshi Shinyama Breakdown of academic impact, for papers by Kazunori Utsunomiya Breakdown of academic impact, for papers by Aurélie Nguyen Dinh Cat Breakdown of academic impact, for papers by Andrea Semplicini Breakdown of academic impact, for papers by Felipe Inserra
Rankless by CCL
2026